Autolus Therapeutics Plc (AUTL)
1.46
-0.07
(-4.58%)
USD |
NASDAQ |
Jun 08, 16:00
1.46
0.00 (0.00%)
After-Hours: 07:41
Autolus Therapeutics Profit Margin (Quarterly) : -273.1% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | -307.5% |
| Akari Therapeutics Plc | -- |
| Grifols SA | 5.18% |
| Evaxion AS | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -113.7% |
| Return on Assets | -44.50% |
| Return on Invested Capital | -49.08% |
| Gross Profit Margin (Quarterly) | 6.29% |
| Operating Margin (Quarterly) | -227.0% |
| Return on Net Operating Assets | -136.8% |